Page last updated: 2024-10-26

etidronate and Gastric Diseases

etidronate has been researched along with Gastric Diseases in 2 studies

Etidronic Acid: A diphosphonate which affects calcium metabolism. It inhibits ectopic calcification and slows down bone resorption and bone turnover.
etidronic acid : A 1,1-bis(phosphonic acid) that is (ethane-1,1-diyl)bis(phosphonic acid) having a hydroxy substituent at the 1-position. It inhibits the formation, growth, and dissolution of hydroxyapatite crystals by chemisorption to calcium phosphate surfaces.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Valeeva, IKh1
Titarenko, AF1
Ziganshina, LE1
Schlangen, JT1
Pauwels, EK1

Other Studies

2 other studies available for etidronate and Gastric Diseases

ArticleYear
[Comparative analysis of dimephosphon, ionol, and xydiphone effects on indomethacin-induced gastric lesions in rats].
    Eksperimental'naia i klinicheskaia farmakologiia, 2010, Volume: 73, Issue:12

    Topics: Animals; Anti-Inflammatory Agents, Non-Steroidal; Anti-Ulcer Agents; Antioxidants; Bone Density Cons

2010
[The diagnosis of pulmonary calcinosis by scintigraphy (author's transl)].
    RoFo : Fortschritte auf dem Gebiete der Rontgenstrahlen und der Nuklearmedizin, 1976, Volume: 124, Issue:2

    Topics: Adolescent; Adult; Aged; Calcinosis; Diagnosis, Differential; Etidronic Acid; Female; Glomerulonephr

1976